Download PDFPDF

Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Steatosis in chronic Hepatitis C
    • Tarik Asselah, MD, PhD
    • Other Contributors:
      • Laura Rubbia-Brandt, Patrick Marcellin and Francesco Negro

    Dear Editor,

    We appreciate the interest of Guidi et al. according our review about the relevance of steatosis in chronic hepatitis C.[1] We would like to outline three points according to their comments: the prevalence of steatosis in regard to genotype; the role of necroinflammation; the relationship between steatosis and treatment outcome.

    Firstly, several studies have observed a significant association...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Steatosis in Chronic Hepatitis C
    • Marcello Guidi, MD
    • Other Contributors:
      • Paolo Muratori, Alessandro Granito, Luigi Muratori, Marco Lenzi and Francesco B. Bianchi

    Dear Editor,

    we read with great interest the review by Asselah et al. (1), about the relevance of steatosis in chronic hepatitis C. They properly report that steatosis occurs more frequently in patients with chronic hepatitis C (55%) than in the general population (20-30%) of adults in the Western world (2), and that it is associated with various factors, including obesity, high alcohol consumption, diabetes melli...

    Show More
    Conflict of Interest:
    None declared.